EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Selective modulation of epileptic tissue by an adenosine A 3 receptor‐activating drug

Anwesha Ghosh, Leonor Ribeiro-Rodrigues, Gabriele Ruffolo, Veronica Alfano, Cátia Domingos, Nádia Rei, Dilip K Tosh, Diogo M Rombo, Tatiana P Morais, Cláudia A Valente, Sara Xapelli, Beatriz Bordadágua and 9 more

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.17319 ↗

At a glance

Journal article in British Journal of Pharmacology, 2024. Written by Anwesha Ghosh and 20 co-authors. Institution: Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. Major MEDLINE topics: Hippocampus, Receptor, Adenosine A3, Epilepsy, Adenosine A3 Receptor Agonists. Cited 4 times so far (Crossref); 83 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Intramural NIH HHS, Sapienza Università di Roma, Italian Ministry of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Adenosine, through the A 1 receptor (A 1 R), is an endogenous anticonvulsant. The development of adenosine receptor agonists as antiseizure medications has been hampered by their cardiac side effects. A moderately A 1 R‐selective agonist, MRS5474, has been reported to suppress seizures without considerable cardiac action. Hypothesizing that this drug could act through other than A 1 R and/or through a disease‐specific mechanism, we assessed the effect of MRS5474 on the hippocampus. Experimental Approach Excitatory synaptic currents, field potentials, spontaneous activity, [ 3 H]GABA uptake and GABAergic currents were recorded from rodent or human hippocampal tissue. Alterations in adenosine A 3 receptor (A 3 R) density in human tissue were assessed by Western blot. Key Results MRS5474 (50–500 nM) was devoid of effect upon rodent excitatory synaptic signals in hippocampal slices, except when hyperexcitability was previously induced in vivo or ex vivo. MRS5474 inhibited GABA transporter type 1 (GAT‐1)‐mediated γ‐aminobutyric acid (GABA) uptake, an action not blocked by an A 1 R antagonist but blocked by an A 3 R antagonist and mimicked by an A 3 R agonist. A 3 R was overexpressed in human hippocampal tissue samples from patients with epilepsy that had focal resection from surgery. MRS5474 induced a concentration‐dependent potentiation of GABA‐evoked currents in oocytes micro‐transplanted with human hippocampal membranes prepared from epileptic hippocampal tissue but not from non‐epileptic tissue, an action blocked by an A 3 R antagonist. Conclusion and Implications We identified a drug that activates A 3 R and has selective actions on epileptic hippocampal tissue. This underscores A 3 R as a promising target for the development of antiseizure medications.

Subjects

MeSH terms (MEDLINE)

HippocampusReceptor, Adenosine A3EpilepsyAdenosine A3 Receptor AgonistsAnticonvulsantsHumansAnimalsMaleRatsgamma-Aminobutyric AcidFemaleRats, Sprague-DawleyMiceAdenosineExcitatory Postsynaptic PotentialsGABA Plasma Membrane Transport Proteins

Author keywords

GABAergic transmissionadenosine A1 receptoradenosine A3 receptorepilepsyhippocampusneuronal excitability

Substances

Receptor, Adenosine A3Adenosine A3 Receptor AgonistsAnticonvulsantsgamma-Aminobutyric AcidAdenosineGABA Plasma Membrane Transport Proteins

Authors and institutions

  • Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
  • Instituto de Medicina Molecular João Lobo Antunes, Universidade de Lisboa, Lisbon, Portugal.
  • Department of Physiology and Pharmacology, Sapienza University of Rome, Rome, Italy.
  • IRCCS San Raffaele Roma, Rome, Italy.
  • Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Neuroscience Division, School of Bioscience, Cardiff University, Cardiff, UK.

ORCID profiles: Kenneth A Jacobson

Funding

  • Intramural NIH HHS
  • Sapienza Università di Roma
  • Italian Ministry of Health
  • Italian Ministry of University and Research
  • Instituto de Medicina Molecular João Lobo Antunes
  • Fundação para a Ciência e a Tecnologia
  • International Society for Neurochemistry
  • H2020-WIDESPREAD-05-2017-Twinning (EpiEpiNet)

Cite

APA

Ghosh, A., Ribeiro-Rodrigues, L., Ruffolo, G., Alfano, V., Domingos, C., Rei, N., Tosh, D. K., Rombo, D. M., Morais, T. P., Valente, C. A., Xapelli, S., Bordadágua, B., Rainha-Campos, A., Bentes, C., Aronica, E., Diógenes, M. J., Vaz, S. H., Ribeiro, J. A., Palma, E., …, & Sebastião, A. M. (2024). Selective modulation of epileptic tissue by an adenosine A 3 receptor‐activating drug. British Journal of Pharmacology. https://doi.org/10.1111/bph.17319

Vancouver

Ghosh A, Ribeiro-Rodrigues L, Ruffolo G, Alfano V, Domingos C, Rei N, et al. Selective modulation of epileptic tissue by an adenosine A 3 receptor‐activating drug. British Journal of Pharmacology. 2024. doi:10.1111/bph.17319

BibTeX
@article{Ghosh2024,
  author = {Ghosh, Anwesha and Ribeiro-Rodrigues, Leonor and Ruffolo, Gabriele and Alfano, Veronica and Domingos, Cátia and Rei, Nádia and Tosh, Dilip K and Rombo, Diogo M and Morais, Tatiana P and Valente, Cláudia A and Xapelli, Sara and Bordadágua, Beatriz and Rainha-Campos, Alexandre and Bentes, Carla and Aronica, Eleonora and Diógenes, Maria José and Vaz, Sandra H and Ribeiro, Joaquim A and Palma, Eleonora and Jacobson, Kenneth A and Sebastião, Ana M},
  title = {Selective modulation of epileptic tissue by an adenosine A 3 receptor‐activating drug},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.17319}
}
Start for free →